3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Terminated
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Melanoma
3
Carcinoma, Non-Small-Cell Lung
3
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
Uveal Melanoma
1
Turcot syndrome
1
Sarcoma
1
Post-Acute COVID-19 Syndrome
1
Pancreatic Neoplasms
1
Lung Neoplasms
1
Liver Neoplasms
1
Fibrolamellar hepatocellular carcinoma
1
Clear-cell metastatic renal cell carcinoma
1
Carcinoma
1
Advanced Kidney Cancer
1
Interventions
pembrolizumab
3
sintilimab
1
XELOX
1
Surgical Procedures, Operative
1
Nivolumab
1
Megestrol Acetate
1
Medroxyprogesterone Acetate
1
Ipilimumab
1
Induction Chemotherapy
1
Immunotherapy
1
DNA Mismatch Repair
1
DEAE-Dextran
1
Colonoscopy
1
Chemotherapy, Adjuvant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Turcot syndrome
×
Ipilimumab
×
Clear all
NCT07403877
2026-02-11
TORCH-OPTIMA
Fudan University
Phase 2
Not yet recruiting
114 enrolled